2016-04-25 15:38:59 UTC

2016 Freston Conference: A Look at Session One

April 26, 2016

Learn what to expect at the first session of the August conference, which focuses on intestinal metaplasia.

Faculty from the upcoming 2016 James W. Freston Conference, which takes place Aug. 19 through 21 in Chicago, IL, are excited to provide more details about the upcoming conference. Over the next few weeks, we’ll highlight sessions from the conference and provide you with insight on what you can expect to be addressed. This week, we've outlined highlights from the first session.

Intestinal Metaplasia in the Esophagus and Stomach: Clinical and Historical Issues
The 2016 conference kicks things off by examining key clinical and histological features of intestinal metaplasia. Specifically, attendees will be able to:

  • Get clarification on the histological and biochemical differences between intestinal metaplasia in the esophagus and stomach.
  • Outline the risk of cancer for cardiac mucosa.
  • Determine if cardiac mucosa is metaplastic.

Be sure to check the May 5 issue of AGA eDigest and the AGA website for details on session two. To view the program in its entirety, visit the conference Web page.

More on Continuing Education

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Nov. 14, 2017

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.